All these targets showed relationship with cancer like Pregnane X receptor (PXR), or NR1I2, is a transcription factor that controls genes related to pharmacokinetics, chemotherapy resistance, and the advancement of cancer [65]. This evidence concerns the gene NR1I2 and cancer.